Use of non-prescribed methadone and other illicit drugs during methadone maintenance treatment

Drug and Alcohol Review

Volumn 19, Issue 1, 2000, Pages 9-16

  Best, David ^a   Harris, Jenny ^a   Gossop, Michael ^a,b   Farrell, Michael ^a   Finch, Emily ^a   Noble, Alison ^a   Strang, John ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Department of Research ^*

Author keywords

Diazepam; Follow up research; Methadone diversion; Methadone maintenance; Non prescribed drug use

Indexed keywords

EID: 0034385231     PISSN: 09595236     EISSN: None     Source Type: Journal    
DOI: 10.1080/09595230096093     Document Type: Article

References (29)

1. Gossop M, Marsden J, Stewart D, et al. The National Treatment Outcome Research Study in the United Kingdom: 6-month follow-up outcomes. Psychology of Addictive Behaviors 1997;11:324-37.
2. Ball JC, Ross A. The effectiveness of methadone maintenance treatment. New York: Springer-Verlag, 1991.
3. Hubbard RL, Marsden ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzburg HM. Drug abuse treatment: a national study of effectiveness. North Carolina: University of North Carolina Press, 1989.
4. Simpson DD, Sells SB. Effectiveness of treatment for drug abuse: an overview of the DARP research program. Adv Alcohol Subst Abuse 1982;2:7-29.
5. Gossop M, Marsden J, Stewart D. The National Treatment Outcome Research Study: at one year. Changes in substance use, health and criminal behaviour one year after intake. London: Department of Health, 1998.
6. McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA 1993;269: 1953-9.
7. Kraft K, Rothbard AB, Hadley TR, MacLellan AT, Asch DA. Are supplementary services provided during methadone maintenance really cost-effective? Am J Psychiatry 1997;154:1214-19.
8. Handal PJ, Lander JJ. Methadone treatment: program evaluation and dose-response relationship. Int J Addict 1976;11:363-75.
9. McGlothlin WH, Anglin MD. Long-term follow-up of clients of high- and low-dose methadone programs. Arch Gen Psychiatry 1981;38:1055-63.
10. Dole VP. Interim methadone clinics: an under-valued approach. Am J Public Health 1991;81: 1111-12.
11. Cooper J, Altman F, Keeley K. Discussion summary (of W. A. Hargreaves, Methadone dosage and duration for methadone treatment). In: Cooper JR, Altman F, Brown BS, Czechowicz D, eds. Research on the treatment of narcotic addiction: state of the art. Maryland: NIDA, US Department of Health and Human Sciences, 1983, 92-94.
12. Rhoades HM, Creson D, Elk R, Schmitz J, Grabowski J. Retention, HIV risk and illicit drug use during treatment: methadone dose and visit frequency. Am J Public Health 1998;88:34-39.
13. Strain E, Bigelow G, Liebson I, Stitzer M. Moderate-vs high-dose methadone in the treatment of opioid dependence: a randomised trial. JAMA 281;1000-5.
14. Ward J, Mattick R, Hall W. Key issues in methadone maintenance treatment. New South Wales: New South Wales University Press, 1992.
15. Scow SSW, Swensen G, Willis D, Hartfield M, Chapman C. Extraneous drug use in methadone maintenance-supported patients. Med J Aust 1980;1:269-71.
16. Maddux JF, Esquivel M, Vogtsberger KN, Desmond DP. Methadone dose and urine morphine. J Subst Abuse Treat 1991;8:195-201.
17. Mino A, Page D, Dumont P, Broers B. Treatment failure and methadone dose in a public methadone maintenance treatment programme in Geneva. Drug Alcohol Depend 1998;50:233-9.
18. Stastny D, Potter M. Alcohol abuse by patients undergoing methadone treatment programmes. Br J Addict 1991;86:307-10.
19. Brown BS, Kozel NJ, Meyers BM, DuPont RL. Use of alcohol by addict and nonaddict populations. Am J Psychiatry 1973;130:599-601.
20. Liebson I, Bigelow G, Flamer R. Alcoholism among methadone patients. A special treatment method. Am J Psychiatry 1973;130:483-5.
21. Lauzon P, Vincelette J, Bruneau J, et al. Illicit use of methadone among IV drug users in Montreal. J Subst Abuse Treat 1994;11:457-61.
22. Weppner RS, Stephens RC. The illicit use and diversion of methadone on the streets as related by hospitalised addicts. J Drug Issues 1973;3:42-8.
23. Spunt B, Hunt DE, Lipton DS, Goldsmith DS. Methadone diversion: a new look. J Drug Issues 1986;16:569-83.
24. Sheridan J, Strang J, Barber N, Glanz A. The role of community pharmacies in relation to HIV prevention and drug misuse: findings from the 1995 national survey in England and Wales. Br Med J 1996;313:272-4.
25. Strang J, Sheridan J. Effect of government recommendations on methadone prescribing in South East England: Comparison of 1995 and 1997 surveys. Br Med J 1999;317:1489-90.
26. Neeleman R, Farrell M. Fatal methadone and heroin overdoses: time trends in England and Wales. J Epidemiol Commun Health 1997;52:435-7.
27. Marsden J, Gossop M, Stewart D, et al. Maudsley Addiction Profile: a brief instrument for assessing treatment outcome. Addiction 1998; 93:1857-68.
28. Ling W, Charuvastra C, Kaim SC, Klett CJ. Methadyl acetate and methadone as maintenance treatments for heroin addicts. Arch Gen Psychiatry 1976;33:709-20.
29. Best D, Gossop M, Marsden J, Farrell M, Strang J. Time of day of methadone consumption and illicit heroin use. Drug Alcohol Depend 1997; 49:49-54.